Is 30-day mortality an adequate outcome statistic for patients considering heart valve replacement?

Edwards, M B; Taylor, Kenneth M.

doi:10.1016/s0003-4975(03)00350-3

Cited by 24 publications

(11 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The double valve replacement surgery is a risk factor for death independent of preoperative data [ 5 ] , mainly due to longer duration of surgery, CPB and aortic clamping [ 2 , 6 , 7 ] .…”

Section: Discussionmentioning

confidence: 99%

Evaluation of variables responsible for hospital mortality in patients with rheumatic heart disease undergoing double valve replacement

Fernandes¹,

Andrade²,

Oliveira³

et al. 2014

Revista Brasileira De Cirurgia Cardiovascular

View full text Add to dashboard Cite

ObjectiveTo describe the hospital mortality and associated clinical and echocardiographic variables in patients with rheumatic disease who underwent double valve replacement surgery.MethodsThis is a cross sectional descriptive study of mortality, performed in a referral hospital in Salvador, Bahia. Records from patients with rheumatic disease who underwent double valve replacement surgery during the years 2007-2011 were analyzed.ResultsThe studied sample comprises 104 patients and 60 (57.7%) were male. The mean age was 38.04±14.45. Sixty five bioprostheses and 38 mechanical prostheses were used in these patients at the time of surgery. There were statistically significant differences between the two groups, when we analyzed the following variables: the mean age (36.30±13.03 vs. 45.35±17.8 years-old, P=0.011), mean hemoglobin (11.10±2.19 vs. 9.22±2.26 g/dL, P=0.002), mean hematocrit (34.22±5.86 vs. 28.44±6.62%, P<0.001). New York Heart Association functional class III and IV (NYHA) (P=0.022) was statistically associated with mortality.ConclusionWe concluded that the mean hemoglobin/hematocrit level and the NYHA functional class was the major variables associated to the mortality among these patients. Based on these data one may concern about the patient best moment for surgery and the patient hemoglobin level.

show abstract

“…The double valve replacement surgery is a risk factor for death independent of preoperative data [ 5 ] , mainly due to longer duration of surgery, CPB and aortic clamping [ 2 , 6 , 7 ] .…”

Section: Discussionmentioning

confidence: 99%

Evaluation of variables responsible for hospital mortality in patients with rheumatic heart disease undergoing double valve replacement

Fernandes¹,

Andrade²,

Oliveira³

et al. 2014

Revista Brasileira De Cirurgia Cardiovascular

View full text Add to dashboard Cite

show abstract

“…Rev Bras Cir Cardiovasc 2010; 25 (1): [11][12][13][14][15][16][17][18] chosen for it has already been part of a line of research of our group.…”

Section: Andrade Ing Et Al -Assessment Of the Euroscore As A Predictmentioning

confidence: 99%

Avaliação do EuroSCORE como preditor de mortalidade em cirurgia cardíaca valvar no Instituto do Coração de Pernambuco

Newton

Andrade

Neto

et al. 2010

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

“…As the main goal of the study is an analysis of the long-term survival of patients, as well as events related to the bioprosthesis, survival curves were calculated from hospital discharge, as the factors determining immediate mortality are mainly related to the clinical condition of the patient and to the surgical procedure, in detriment of the hemodynamic performance and possible complications of the bioprosthesis [22][23][24][25][26].…”

Section: Commentsmentioning

confidence: 99%

Bioprótese valvar de pericárdio bovino St Jude Medical-Biocor: sobrevida tardia

Bacco¹,

Sant'Anna²,

Sant’Anna³

et al. 2005

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

Methods: From 1992 to 2000, 304 patients were discharged from hospital after bioprosthesis implantation. Ages ranged from 15 to 83 years (mean: 60.6 ± ± ± ± ± 14.3 years) and 50.3% were male. Patient deaths and events related to bioprosthesis (infection, thromboembolism and structural failure) were considered for estimation of cumulative probability of survival and event-free survival.Results: Total follow-up was 931.0 patients-year. During follow-up there were 28 (9.2%) deaths. Causes were bioprosthesis failure in five (1.6%), cardiac in seven (2.3%), non-cardiac in four (1.3%), and unknown in 12 (3.9%) patients. Events related to bioprosthesis were: endocarditis: 18 (5.9%), fibrocalcific degeneration: 15 (4.9%), thromboembolism: three (1.0%), hemolysis: one (0.3%). Bioprosthesis dysfunctions resulted in 16 (5.2%) reoperations due to fibrocalcific degeneration (nine), endocarditis (six) and thromboembolism (one). Probability of survival was higher in the young population (< 40 years, n=35) when compared to the older group (> 60 year, n=187): 82.0 ± ± ± ± ± 13.3% vs. 58.8 ± ± ± ± ± 13.6% in the 9 th year. Event-free survival was 77.5 ± ± ± ± ± 3.7% for 5 th year and 40.2 ± ± ± ± ± 9.0% for 10 th year. 424BACCO, FW ET AL -St Jude Medical-Biocor bovine pericardial bioprosthesis: long-term survival Braz J Cardiovasc Surg 2005; 20(4): 423-431 Resultados: Em um seguimento total de 931,0 pacientesano, ocorreram 28 (9,2%) óbitos tardios, sendo cinco (1,6%) relacionados à bioprótese, sete (2,3%) cardíacos, quatro (1,3%) não-cardíacos e 12 (3,9%)

show abstract

Is 30-day mortality an adequate outcome statistic for patients considering heart valve replacement?

Cited by 24 publications

References 3 publications

Evaluation of variables responsible for hospital mortality in patients with rheumatic heart disease undergoing double valve replacement

Evaluation of variables responsible for hospital mortality in patients with rheumatic heart disease undergoing double valve replacement

Avaliação do EuroSCORE como preditor de mortalidade em cirurgia cardíaca valvar no Instituto do Coração de Pernambuco

Bioprótese valvar de pericárdio bovino St Jude Medical-Biocor: sobrevida tardia

Contact Info

Product

Resources

About